Breastfeeding and transmission of viruses other than HIV-1

Advances in Experimental Medicine and Biology

Volumn 743, Issue , 2012, Pages 27-38

  Townsend, Claire L ^a   Peckham, Catherine S ^a   Thorne, Claire ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN; VIRUS DNA;

ADVERSE OUTCOME; ARTICLE; BREAST FEEDING; BREAST MILK; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE CARRIER; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNIZATION; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; LOW BIRTH WEIGHT; MIXED INFECTION; OUTCOME ASSESSMENT; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; VIRUS CARRIER; VIRUS DETECTION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS TRANSMISSION;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84859904575     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-2251-8_2     Document Type: Article

References (99)

1. Junker AK, Thomas EE, Radcliffe A, Forsyth RB, Davidson AG, Rymo L (1991) Epstein-Barr virus shedding in breast milk. Am J Med Sci 302(4):220-223
2. Kusuhara K, Takabayashi A, Ueda K et al (1997) Breast milk is not a signifi cant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic virus type I in Japan. Microbiol Immunol 41(4):309-312
3. Dedicoat M, Newton R, Alkharsah KR et al (2004) Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 190(6):1068-1075
4. Brayfi eld BP, Phiri S, Kankasa C et al (2003) Postnatal human herpesvirus 8 and human immunodefi ciency virus type 1 infection in mothers and infants from Zambia. J Infect Dis 187(4):559-568
5. Fujisaki H, Tanaka-Taya K, Tanabe H et al (1998) Detection of human herpesvirus 7 (HHV-7) DNA in breast milk by polymerase chain reaction and prevalence of HHV-7 antibody in breast-fed and bottle-fed children. J Med Virol 56(3):275-279
6. Kotronias D, Kapranos N (1999) Detection of herpes simplex virus DNA in maternal breast milk by in situ hybridization with tyramide signal amplifi cation. In Vivo 13(6):463-466
7. Sullivan-Bolyai J, Hull HF, Wilson C, Corey L (1983) Neonatal herpes simplex virus infection in King County, Washington. Increasing incidence and epidemiologic correlates. JAMA 250(22):3059-3062
8. Quinn PT, Lofberg JV (1978) Maternal herpetic breast infection: another hazard of neonatal herpes simplex. Med J Aust 2(9):411-412
9. Gantt S, Carlsson J, Shetty AK et al (2008) Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis. AIDS 22(12):1453-1460
10. Buimovici-Klein E, Hite RL, Byrne T, Cooper LZ (1977) Isolation of rubella virus in milk after postpartum immunization. J Pediatr 91(6):939-941
11. Losonsky GA, Fishaut JM, Strussenberg J, Ogra PL (1982) Effect of immunization against rubella on lactation products. II. Maternal-neonatal interactions. J Infect Dis 145(5):661-666
12. Krogh V, Duffy LC, Wong D, Rosenband M, Riddlesberger KR, Ogra PL (1989) Postpartum immunization with rubella virus vaccine and antibody response in breast-feeding infants. J Lab Clin Med 113(6):695-699
13. Bohlke K, Galil K, Jackson LA et al (2003) Postpartum varicella vaccination: is the vaccine virus excreted in breast milk? Obstet Gynecol 102(5 Pt 1):970-977
14. Matheron S, Pueyo S, Damond F et al (2003) Factors associated with clinical progression in HIV-2 infectedpatients: the French ANRS cohort. AIDS 17(18):2593-2601
15. Cavaco-Silva P, Taveira NC, Lourenco MH, Santos Ferreira MO, Daniels RS (1997) Vertical transmission of HIV-2. Lancet 349(9046):177-178
16. (1994) Comparison of vertical human immunodefi ciency virus type 2 and human immunodefi ciency virus type 1 transmission in the French prospective cohort. The HIV Infection in Newborns French Collaborative Study Group. Pediatr Infect Dis J 13(6):502-506
17. Andreasson PA, Dias F, Naucler A, Andersson S, Biberfeld G (1993) A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS 7(7):989-993
18. ODonovan D, Ariyoshi K, Milligan P et al (2000) Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS 14(4): 441-448
19. Adjorlolo-Johnson G, De Cock KM, Ekpini E et al (1994) Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 272(6):462-466
20. Burgard M, Jasseron C, Matheron S et al (2010) Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1. Clin Infect Dis 51(7):833-843
21. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77(12):7415-7419
22. Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79(6):2031-2035
23. Manns A, Blattner WA (1991) The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease. Transfusion 31(1):67-75
24. Goncalves DU, Proietti FA, Ribas JG et al (2010) Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 23(3):577-589
25. Lowis GW, Sheremata WA, Minagar A (2002) Epidemiologic features of HTLV-II: serologic and molecular evidence. Ann Epidemiol 12(1):46-66
26. Mauclere P, Afonso PV, Meertens L et al (2011) HTLV-2B strains, similar to those found in several Amerindian tribes, are endemic in central African Bakola Pygmies. J Infect Dis 203(9):1316-1323
27. Nakano S, Ando Y, Saito K et al (1986) Primary infection of Japanese infants with adult T-cell leukaemia-associated retrovirus (ATLV): evidence for viral transmission from mothers to children. J Infect 12(3):205-212
28. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Nomura H, Okochi K (1986) Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis 154(5):851-857
29. Ureta-Vidal A, Angelin-Duclos C, Tortevoye P et al (1999) Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer 82(6):832-836
30. Fujino T, Nagata Y (2000) HTLV-I transmission from mother to child. J Reprod Immunol 47(2):197-206
31. Sugiyama H, Doi H, Yamaguchi K, Tsuji Y, Miyamoto T, Hino S (1986) Signifi cance of postnatal mother-to-child transmission of human T-lymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma. J Med Virol 20(3):253-260
32. Kusuhara K, Sonoda S, Takahashi K, Tokugawa K, Fukushige J, Ueda K (1987) Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): a fi fteen-year follow-up study in Okinawa, Japan. Int J Cancer 40(6):755-757
33. Carles G, Tortevoye P, Tuppin P et al (2004) HTLV1 infection and pregnancy. J Gynecol Obstet Biol Reprod (Paris) 33(1 Pt 1):14-20
34. Ikeda S, Kinoshita K, Amagasaki T et al (1989) Mother to child transmission of human T cell leukemia virus type-Rinsho Ketsueki 30(10):1732-1737
35. Tsuji Y, Doi H, Yamabe T, Ishimaru T, Miyamoto T, Hino S (1990) Prevention of mother-to-child transmission of human T-lymphotropic virus type-I. Pediatrics 86(1):11-17
36. Hino S (1989) Milk-borne transmission of HTLV-I as a major route in the endemic cycle. Acta Paediatr Jpn 31(4):428-435
37. Oki T, Yoshinaga M, Otsuka H, Miyata K, Sonoda S, Nagata Y (1992) A sero-epidemiological study on motherto- child transmission of HTLV-I in southern Kyushu, Japan. Asia Oceania J Obstet Gynaecol 18(4):371-377
38. Wiktor SZ, Pate EJ, Rosenberg PS et al (1997) Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol 1(1):37-44
39. Takezaki T, Tajima K, Ito M et al (1997) Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. The Tsushima ATL Study Group. Leukemia 11 Suppl 3:60-62
40. Ando Y, Saito K, Nakano S et al (1989) Bottle-feeding can prevent transmission of HTLV-I from mothers to their babies. J Infect 19(1):25-29
41. Ando Y, Matsumoto Y, Nakano S et al (2003) Long-term follow up study of vertical HTLV-I infection in children breast-fed by seropositive mothers. J Infect 46(3):177-179
42. Ureta-Vidal A, Angelin-Duclos C, Tortevoye P et al (1999) Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer 82(6):832-836
43. Hisada M, Maloney EM, Sawada T et al (2002) Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica. Clin Infect Dis 34(12):1551-1557
44. Wiktor SZ, Pate EJ, Murphy EL et al (1993) Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) in Jamaica: association with antibodies to envelope glycoprotein (gp46) epitopes. J Acquir Immune Defi c Syndr 6(10):1162-1167
45. Maehama T, Nakayama M, Nagamine M, Nakashima Y, Takei H, Nakachi H (1992) Studies on factor affecting mother-to-child HTLV-I transmission. Nippon Sanka Fujinka Gakkai Zasshi 44(2):215-222
46. Takahashi K, Takezaki T, Oki T et al (1991) Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. The Mother-to-Child Transmission Study Group. Int J Cancer 49(5):673-677
47. Hino S, Katamine S, Miyamoto T et al (1995) Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of human T-lymphotropic virus type I. Maternal anti-env antibodies correlate with protection in non-breast-fed children. J Clin Invest 95(6):2920-2925
48. Gotuzzo E, Moody J, Verdonck K et al (2007) Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis or strongyloidiasis. Rev Panam Salud Publica 22(4):223-230
49. Kaplan JE, Osame M, Kubota H et al (1990) The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defi c Syndr 3(11):1096-1101
50. Murphy EL, Fridey J, Smith JW et al (1997) HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-IIinfected blood donors. The REDS investigators. Neurology 48(2):315-320
51. Van Dyke RB, Heneine W, Perrin ME et al (1995) Mother-to-child transmission of human T-lymphotropic virus type II. J Pediatr 127(6):924-928
52. Bittencourt AL, Primo J, Oliveira MF (2006) Manifestations of the human T-cell lymphotropic virus type I infection in childhood and adolescence. J Pediatr (Rio J) 82(6):411-420
53. Maloney EM, Yamano Y, Vanveldhuisen PC et al (2006) Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica. J Infect Dis 194(5):552-560
54. Mahe A, Meertens L, Ly F et al (2004) Human T-cell leukaemia/lymphoma virus type 1-associated infective dermatitis in Africa: a report of fi ve cases from Senegal. Br J Dermatol 150(5):958-965
55. Oni T, Djossou F, Joubert M, Heraud JM (2006) Awareness of mother-to-child transmission of human T-cell lymphotropic virus (HTLV) type I through breastfeeding in a small group of HTLV-positive women in Maripasoula and Papaichton, French Guiana. Trans R Soc Trop Med Hyg 100(8):715-718
56. Hino S, Katamine S, Miyata H, Tsuji Y, Yamabe T, Miyamoto T (1996) Primary prevention of HTLV-I in Japan. J Acquir Immune Defi c Syndr Hum Retrovirol 13(Suppl 1):S199-S203
57. Kashiwagi K, Furusyo N, Nakashima H et al (2004) A decrease in mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan. Am J Trop Med Hyg 70(2):158-163
58. Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17(5):355-363
59. Diosi P, Babusceac L, Nevinglovschi O, Kun-Stoicu G (1967) Cytomegalovirus infection associated with pregnancy. Lancet 2(7525):1063-1066
60. Hayes K, Danks DM, Gibas H, Jack I (1972) Cytomegalovirus in human milk. N Engl J Med 287(4):177-178
61. Stagno S, Reynolds DW, Pass RF, Alford CA (1980) Breast milk and the risk of cytomegalovirus infection. N Engl J Med 302(19):1073-1076
62. Peckham CS, Johnson C, Ades A, Pearl K, Chin KS (1987) Early acquisition of cytomegalovirus infection. Arch Dis Child 62(8):780-785
63. Vochem M, Hamprecht K, Jahn G, Speer CP (1998) Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J 17(1):53-58
64. Yasuda A, Kimura H, Hayakawa M et al (2003) Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay. Pediatrics 111(6 Pt 1):1333-1336
65. Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G (2001) Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 357(9255):513-518
66. Jim WT, Shu CH, Chiu NC et al (2004) Transmission of cytomegalovirus from mothers to preterm infants by breast milk. Pediatr Infect Dis J 23(9):848-851
67. Croly-Labourdette S, Vallet S, Gagneur A et al (2006) Pilot epidemiologic study of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Arch Pediatr 13(7):1015-1021
68. Kurath S, Halwachs-Baumann G, Muller W, Resch B (2010) Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review. Clin Microbiol Infect 16(8):1172-1178
69. Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17(4):253-276
70. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM (2002) Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 57(4):245-256
71. Dworsky M, Yow M, Stagno S, Pass RF, Alford C (1983) Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 72(3):295-299
72. Maschmann J, Hamprecht K, Dietz K, Jahn G, Speer CP (2001) Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clin Infect Dis 33(12):1998-2003
73. Townsend CL, Peckham CS, Tookey PA (2011) Surveillance of congenital cytomegalovirus in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. doi:10.1136/adc.2010.199901
74. Vollmer B, Seibold-Weiger K, Schmitz-Salue C et al (2004) Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants. Pediatr Infect Dis J 23(4):322-327
75. Paryani SG, Yeager AS, Hosford-Dunn H et al (1985) Sequelae of acquired cytomegalovirus infection in premature and sick term infants. J Pediatr 107(3):451-456
76. Schleiss MR (2006) Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern? Rev Med Virol 16(2):73-82
77. Friis H, Andersen HK (1982) Rate of inactivation of cytomegalovirus in raw banked milk during storage at 20 degrees C and pasteurisation. Br Med J (Clin Res Ed) 285(6355):1604-1605
78. Hamprecht K, Maschmann J, Muller D et al (2004) Cytomegalovirus (CMV) inactivation in breast milk: reassessment of pasteurization and freeze-thawing. Pediatr Res 56(4):529-535
79. Sharland M, Khare M, Bedford-Russell A (2002) Prevention of postnatal cytomegalovirus infection in preterm infants. Arch Dis Child Fetal Neonatal Ed 86(2):F140
80. Merrill RM, Hunter BD (2011) Seroprevalence of markers for hepatitis B viral infection. Int J Infect Dis 15(2):e78-e121
81. Liu CY, Chang NT, Chou P (2007) Seroprevalence of HBV in immigrant pregnant women and coverage of HBIG vaccine for neonates born to chronically infected immigrant mothers in Hsin-Chu County, Taiwan. Vaccine 25(44):7706-7710
82. Linnemann CC Jr, Goldberg S (1974) Letter: HBAg in breast milk. Lancet 2(7873):155
83. Lin HH, Hsu HY, Chang MH, Chen PJ, Chen DS (1993) Hepatitis B virus in the colostra of HBeAg-positive carrier mothers. J Pediatr Gastroenterol Nutr 17(2):207-210
84. de Oliveira PR, Yamamoto AY, de Souza CB et al (2009) Hepatitis B viral markers in banked human milk before and after Holder pasteurization. J Clin Virol 45(4):281-284
85. Shi Z, Yang Y, Wang H et al (2011) Breastfeeding of newborns by mothers carrying hepatitis B virus: a metaanalysis and systematic review. Arch Pediatr Adolesc Med 165(9):837-46
86. Beasley RP, Stevens CE, Shiao IS, Meng HC (1975) Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet 2(7938):740-741
87. Sacher M, Eder G, Baumgarten K, Thaler H (1983) Vertical transmission of hepatitis B. Results of a prospective study 1978 to 1981. Wien Klin Wochenschr 95(13):447-451
88. de Martino M, Resti M, Appendino C, Vierucci A (1987) Different degree of antibody response to hepatitis B virus vaccine in breast- and formula-fed infants born to HBsAg-positive mothers. J Pediatr Gastroenterol Nutr 6(2):208-211
89. Wang JS, Zhu QR, Wang XH (2003) Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract 57(2):100-102
90. Hill JB, Sheffi eld JS, Kim MJ, Alexander JM, Sercely B, Wendel GD (2002) Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 99(6):1049-1052
91. Kumar RM, Shahul S (1998) Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. J Hepatol 29(2):191-197
92. Lin HH, Kao JH, Hsu HY et al (1995) Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr 126(4):589-591
93. Spencer JD, Latt N, Beeby PJ et al (1997) Transmission of hepatitis C virus to infants of human immunodefi ciency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat 4(6):395-409
94. Polywka S, Schroter M, Feucht HH, Zollner B, Laufs R (1999) Low risk of vertical transmission of hepatitis C virus by breast milk. Clin Infect Dis 29(5):1327-1329
95. Kage M, Ogasawara S, Kosai K et al (1997) Hepatitis C virus RNA present in saliva but absent in breast-milk of the hepatitis C carrier mother. J Gastroenterol Hepatol 12(7):518-521
96. Pembrey L, Newell ML, Tovo PA (2005) The management of HCV infected pregnant women and their children European paediatric HCV network. J Hepatol 43(3):515-525
97. Gibb DM, Goodall RL, Dunn DT et al (2000) Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 356(9233):904-907
98. Resti M, Azzari C, Mannelli F et al (1998) Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 317(7156):437-441
99. European paediatric Hepatitis C Network (2001) Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. BJOG 108(4):371-377